Advanced search
Publication Cover
Expert Review of Pharmacoeconomics & Outcomes Research Volume 11, 2011 - Issue 1
Submit an article Journal homepage
94
Views
6
CrossRef citations to date
0
Altmetric
Research Report

Does adjusting for health-related quality of life matter in economic evaluations of cancer-related interventions?

Dan Greenberg The Center for the Evaluation of Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; Department of Health Systems Management, Ben-Gurion University of the Negev, PO Box 65, Beer-Sheva 84105, Israel. [email protected]; Department of Health Systems Management, Ben-Gurion University of the Negev, PO Box 65, Beer-Sheva 84105, Israel. [email protected]
&
Peter J Neumann The Center for the Evaluation of Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA; The Center for the Evaluation of Value and Risk in Health, The Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
Pages 113-119 | Published online: 09 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Matthias Schwenkglenks & Klazien Matter-Walstra. (2016) Is the EQ-5D suitable for use in oncology? An overview of the literature and recent developments. Expert Review of Pharmacoeconomics & Outcomes Research 16:2, pages 207-219.
Read now

Articles from other publishers (5)

Teja ThoratPeter J. NeumannJames D. Chambers. (2018) Hemophilia Burden of Disease: A Systematic Review of the Cost-Utility Literature for Hemophilia. Journal of Managed Care & Specialty Pharmacy 24:7, pages 632-642.
Crossref
Scott Grosse. (2015) When is Genomic Testing Cost-Effective? Testing for Lynch Syndrome in Patients with Newly-Diagnosed Colorectal Cancer and Their Relatives. Healthcare 3:4, pages 860-878.
Crossref
David E. Cohn, Jason C. Barnett, Lari Wenzel, Bradley J. Monk, Robert A. Burger, J. Michael StraughnJr.Jr., Evan R. Myers & Laura J. Havrilesky. (2015) A cost–utility analysis of NRG Oncology/Gynecologic Oncology Group Protocol 218: Incorporating prospectively collected quality-of-life scores in an economic model of treatment of ovarian cancer. Gynecologic Oncology 136:2, pages 293-299.
Crossref
Nalin Payakachat, J. Mick Tilford, Karen A. Kuhlthau, N. Job van Exel, Erica Kovacs, Jayne Bellando, Jeffrey M. Pyne & Werner B.F. Brouwer. (2014) Predicting Health Utilities for Children With Autism Spectrum Disorders. Autism Research 7:6, pages 649-663.
Crossref
Joanna Jakubiak-Lasocka & Michał Jakubczyk. (2014) Cost-effectiveness versus Cost-Utility Analyses: What Are the Motives Behind Using Each and How Do Their Results Differ?—A Polish Example. Value in Health Regional Issues 4, pages 66-74.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.